Abstract
In this article the value of structural and functional imaging in aiding the diagnosis and management of Parkinson's disease is reviewed. The underlying pathological mechanisms leading to tremor, coexistent dementia and depression in PD are considered and the role of imaging as a biomarker for testing neuroprotective agents debated.
Publication types
-
Research Support, Non-U.S. Gov't
-
Review
MeSH terms
-
Catecholamines / metabolism
-
Dementia / complications
-
Depression / complications
-
Diagnostic Imaging / methods*
-
Humans
-
Outcome Assessment, Health Care
-
Parkinson Disease / diagnosis*
-
Parkinson Disease / etiology
-
Parkinson Disease / therapy*
-
Tremor / complications